Free-cash-flow proxy increased 23.6%
Free-cash-flow proxy changed +23.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$107.0M→-$81.7M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ALMS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 23.4%
Operating cash flow changed +23.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$106.4M→-$81.5M3 prior comparisons
Operating margin moved 368485 bp lower
Operating margin changed -368485 basis points from the comparable as-filed period.
-5271.53%→-8956.38%0 prior comparisons
Revenue decreased 37.7%
Revenue changed -37.7% from the comparable as-filed period.
$2.7M→$1.7M0 prior comparisons
Cash & equivalents decreased 58.0%
Cash & equivalents changed -58.0% from the comparable as-filed period.
$151.8M→$63.7M2 prior comparisons
Research & development decreased 21.5%
Research & development changed -21.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$108.8M→$85.3M2 prior comparisons
Stock-based compensation decreased 23.4%
Stock-based compensation changed -23.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$18.6M→$14.3M2 prior comparisons
Capital expenditure decreased 61.5%
Capital expenditure changed -61.5% from the comparable as-filed period.
$616,000→$237,0003 prior comparisons
Capex / revenue moved 885 bp lower
Capex / revenue changed -885 basis points from the comparable as-filed period.
23.11%→14.26%0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.